Clinical and epidemic characterization of the illnesses hepatobiliares in pregnant

Authors

Keywords:

hepatobiliary diseases, pregnant women, transaminases

Abstract

Introduction: Liver diseases, as a complication of pregnancy, occur in around 3% of pregnant women; They range from insignificant biochemical alterations to severe liver failure.

Objective: To describe the clinical and epidemiological characteristics of hepatobiliary diseases in a group of pregnant patients.

Material and methods: A descriptive and retrospective study was carried out on 46 pregnant women, who met the inclusion criteria (diagnosis of liver disease concomitant with pregnancy, chronic liver disease concomitant with pregnancy, and pregnancy-specific liver disease); Cases with individual clinical history with insufficient data were excluded. The variables analyzed were: age groups, personal pathological history, liver diseases and laboratory tests. The results were expressed in absolute numbers and percentages.

Results: Hyperemesis gravidarum occurred in 26 (56.5 %) patients, followed by intrahepatic cholestasis of pregnancy (12; 26 %) and gallstones (10; 32.6 %) during pregnancy. There were 18 (39.1 %) pregnant women between 31-35 years old. The four patients with preeclampsia had elevated hypertransaminasemia (15.4 %), GGT (8.7 %), and total bilirubin (15.4 %).  In the case of acute fatty liver of pregnancy, the two patients with this diagnosis showed alterations in all parameters (transaminases, GGT, FA and bilirubin).

Conclusions: Hyperemesis gravidarum and gallstones were the most common pregnancy-specific liver disease and hepatobiliary disease concomitant with pregnancy, respectively.  There was a predominance of patients aged between 31-35 years. Transaminases were the laboratory parameter with the most effects in these diseases.

Author Biographies

Danely Mendoza Jimenez, Hospital Celestino Hernández Robau

Especialista en 1er Grado MGI

Especialista en 1er Grado Gastroenterología

Ramón Romero Borges, Unidad de Toxicología Experimental Universidad de Ciencias Medicas Villa Clara

Investigador y Profesor Universitario.

References

1. Piechota J, Jelski W. Intrahepatic Cholestasis in Pregnancy: Review of the Literature. J Clin Med. 2020; 9 (5): 1361. DOI: https://doi.org/10.3390/jcm9051361

2. Chahal D, Yoshida EM, Arbour L, Wallach JP. Post-partum Primary Biliary Cholangitis Preceded by Intrahepatic Cholestasis of Pregnancy in Three First Nation Patients. Dig Dis Sci. 2021; 66 (4): 1367-1369. DOI: https://doi.org/10.1007/s10620-020-06333-z

3. Arriaga LA, Rosales LA, Martínez RLN, et al. Intrahepatic Cholestasis of Pregnancy. One More Challenge for Obstetrics. Rev Fac Med UNAM [Internet]. 2021 [acceso: 12/09/2023]; 64 (3):20-36. Disponible en:: https://www.medigraphic.com/cgibin/new/resumen.cgi?IDARTICULO=99984

4. Espinoza Artavia AL, Vílchez León M, Webb Webb K. Colestasis intrahepática del embarazo. Revista Médica Sinergia [Internet]. 2019 [acceso: 10/10/2024]; 4 (6): 14-23. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/196

5. Murillo Sanabria MF, Jiménez Alfaro S, Kagi Barquero M. Colestasis intrahepática del embarazo. Revista Médica Sinergia [Internet]. 2020; 5 (11): 2215-4523. Disponible en: http://revistamedicasinergia.com

6. Nelson DB, Schell R. Acute Fatty Liver of Pregnancy. Contemporary OB/GYN Journal [Internet]. 2021 [acceso: 12/09/2023]; 66 (6). Disponible en: https://www.contemporaryobgyn.net/view/acute-fatty-liver-of-pregnancy

7. Guszczynska Losy M, Wirstlein PK, Wender Ozegowska E, Kedzia M. Evaluation of predictive value of biochemical markers for adverse obstetrics outcomes in pregnancies complicated by cholestasis. Ginekol Pol. 2020; 91 (5): 269-276. DOI: https://doi.org/10.5603/GP.2020.0051

8. Mor M, Shmueli A, Krispin E, Bardin R, Sneh-Arbib O, Braun M, Arbib N, Hadar E. Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia. Arch Gynecol Obstet. 2020; 301 (3): 655-664. DOI: https://doi.org/10.1007/s00404-020-05456-y

9. Manzotti C, Casazza G, Stimac T, Nikolova D, Gluud C. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev. 2019; 7 (7): CD012546. DOI: https://doi.org/10.1002/14651858.CD012546.pub2

10. Wood AM, Livingston EG, Hughes BL, Kuller JA. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. Obstet Gynecol Surv. 2018; 73 (2): 103-109. DOI: https://doi.org/10.1097/OGX.0000000000000524

11. Hobson SR, Cohen ER, Gandhi S, Jain V, Niles KM, Roy-Lacroix M, et al. Guideline No. 452: Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy. Journal of Obstetrics and Gynaecology Canada. 2024; 46 (8): 1701-2163. DOI: https://doi.org/10.1016/j.jogc.2024.102618

12. Zhang Q, Xu Y, Gong Y, Liu X. The impact of assisted reproductive technology in twin pregnancies complicated by intrahepatic cholestasis: a five-year retrospective study. BMC Pregnancy Childbirth. 2022; 22 (1): 269. DOI: https://doi.org/10.1186/s12884-022-04610-5

13. Asociación Médica Mundial AMM. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. 64ª Asamblea General; 2013 octubre. Fortaleza, Brasil: Asociación Médica Mundial (AMM); 2013. [acceso: 03/09/2023]. Disponible en: http://www.wma.net/es/30publications/10policies/b3/

14. Oro Luis G, Correa Elizabeth M, Calle Luisa F, Ocampo A, Vélez Sandra M. Enfermedades hepáticas y embarazo. Rev Col Gastroenterol [Internet]. 2019 [acceso: 20/12/2024]; 34(4): 385-398. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-99572019000400385&lng=en

15. Vanterpool HM, Ávalos García R, Corrales Alonso S, Del Valle LLufrio P, Hernández Hernández R. Comportamiento de las hepatopatías en el embarazo valoradas por gastroenterología. Rev Med Electrón [Internet]. 2020 [acceso: 20/12/2024]; 42 (3): 1815-1825. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242020000301815&lng=es

16. Cabrera Ramos SG. Complicaciones obstétricas y edad materna avanzada. Rev. peru. ginecol. obstet [Internet]. 2023 [acceso: 20/12/2024]; 69 (3): 00012. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2304-51322023000300012&lng=es

17. Ma K, Berger D, Reau N. Liver Diseases During Pregnancy. Clinics in Liver Disease. 2019; 23 (2): 345–61. DOI: https://dx.doi.org/10.18565/aig.2022.11.14-22

18. Fallatah HI, Al-Dabbagh AA, Mimish HL, Al-Sahafi MA, Akbar HO. Liver diseases in pregnancy and outcomes: A retrospective study from Saudi Arabia. African Journal of Reproductive Health [Internet]. 2021 [acceso: 05/10/2023]; 25 (3): 121–9. Disponible en: https://ucc.idm.oclc.org/login?URL=https://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=151253834&site=ehost-live

19. Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. American Journal of Gastroenterology [Internet]. 2016 [acceso: 05/01/2023] ;111(2):176–94. Disponible en: https://journals.lww.com/ajg/Fulltext/2016/02000/ACG_Clinical_Guideline__Liver_Disease_and.15.aspx

20. Azzaroli F, Mazzella G, Marchesini G, Brodosi L, Petroni ML. Fatty liver in pregnancy: a narrative review of two distinct conditions. Expert Review of Gastroenterology and Hepatology. 2020; 14 (2): 127–35. DOI: https://doi.org/10.1080/17474124.2020.1715210

Published

2024-10-13

How to Cite

1.
Mendoza Jimenez D, Romero Borges R, Ojeda Blanco JC, Reyes Vera JM. Clinical and epidemic characterization of the illnesses hepatobiliares in pregnant. Invest Medicoquir [Internet]. 2024 Oct. 13 [cited 2025 Dec. 5];16(1):e862. Available from: https://revcimeq.sld.cu/index.php/imq/article/view/862

Issue

Section

Research article